Previously, it was found that Baixiangdan capsules improved PMS/PMDD symptoms by regulating signal pathways such as neuroactive ligand–receptor interactions, mitogen-activated protein kinase, calcium, and gamma-aminobutyric acid signal transduction (Wei et al., 2018). The gene discussed is WNK2; the disease is premenstrual tension.